Adenomyosis: Review of the Literature

Journal of Minimally Invasive Gynecology

Volumn 18, Issue 4, 2011, Pages 428-437

  Garcia, Lydia ^a   Isaacson, Keith ^a  

^a NEWTON WELLESLEY HOSPITAL   (United States)

Author keywords

Adenomyosis; Diagnosis; Dysmenorrhea; Menorrhagia; Pathogenesis; Treatment; Uterus

Indexed keywords

AROMATASE INHIBITOR; DANAZOL; ESTRADIOL RECEPTOR; GONADORELIN AGONIST; LEVONORGESTREL; MEDROXYPROGESTERONE; NORETHISTERONE ACETATE;

ACNE; ADENOMYOSIS; AMENORRHEA; BLEEDING; BONE DENSITY; BREAST TENDERNESS; CURETTAGE; DECIDUALIZATION; DEPRESSION; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DYSMENORRHEA; ELECTROCOAGULATION; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; ESTROGEN SYNTHESIS; FEMALE INFERTILITY; FOLLOW UP; HEADACHE; HIRSUTISM; HOT FLUSH; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; IMMUNOCHEMISTRY; INTRAUTERINE CONTRACEPTIVE DEVICE; MACROPHAGE; MENORRHAGIA; MOOD CHANGE; MUSCLE CRAMP; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; OILY SKIN; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; TRANSVAGINAL ECHOGRAPHY; TREATMENT RESPONSE; UTERINE ARTERY EMBOLIZATION; VISUAL ANALOG SCALE; WEIGHT GAIN;

ENDOMETRIOSIS; FEMALE; HUMANS;

EID: 79960459553     PISSN: 15534650     EISSN: 15534669     Source Type: Journal    
DOI: 10.1016/j.jmig.2011.04.004     Document Type: Review

References (85)

1. Benadiano G., Bronsen I. History of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006, 20:449-463.
2. Benagiano G., Brosens I., Carrara S. Adenomyosis: new knowledge is generating new treatment strategies. Women's Health 2009, 5:297-311.
3. Bird C., McElin T., Manalo-Estrella P. The elusive adenomyosis of the uterus revisited. Am J Obstet Gynecol 1972, 112:583-593.
4. Ferenczy A., Bronsen I. Pathophysiology of adenomyosis. Hum Reprod Update 1998, 4:312-322.
5. Ota H., Igarshi S., Hatazawa J., et al. Is adenomyosis an immune disease?. Hum Reprod 1998, 4:360-367.
6. Bergeron C., Amant F., Ferency A. Pathology and physiology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006, 20:511-521.
7. Yamamoto T., Noguchi T., Tamura T., et al. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 1993, 169:734-738.
8. Matsumoto Y., Iwasaka T., Yamasaki F., et al. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999, 94:71-77.
9. Propst A., Quade B., Garguilo A., et al. Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium. Menopause 2001, 8:368-371.
10. Du H., Taylor H.S. Stem cell and female reproduction. Reprod Sci 2009, 16:126-139.
11. Sasson I., Taylor H.S. Stem cells and the pathogenesis of endometriosis. Ann NY Acad Sci 2008, 1127:106-115.
12. Azzi R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989, 16:221-235.
13. Benson R.C., Sneeden V.D. Adenomyosis: a reappraisal of symptomatology. Am J Obstet Gynecol 1958, 76:1044-1057.
14. Emge L.A. The elusive adenomyosis of the uterus. Am J Obstet Gynecol 1962, 83:1541-1563.
15. Bergholt T., Eriksen L., Ferendt N., et al. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 2001, 16:2418-2421.
16. Farquhar C., Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006, 20:603-626.
17. Uduwela A., Perra M., Aiquig L., et al. Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy. Obstet Gynecol Surv 2000, 55:390-400.
18. Fernandez C., Ricci P., Fernandez E. Adenomyosis visualized during hysteroscopy. J Minim Invasive Gynecol 2007, 14:555-556.
19. Molinas C., Campo R. Office hysteroscopy and adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006, 20:557-567.
20. McCausland A.M. Hysteroscopic myometrial biopsy: its use in diagnosing adenomyosis and its clinical applications. Am J Obstet Gynecol 1992, 166:1619-1626.
21. Popp L., Schwiedessen J., Gaetje R. Myometrial biopsy in the diagnosis of adenomyosis uteri. Am J Obstet Gynecol 1993, 16:546-549.
22. Brosens J., Barker J. The role of myometrial needle biopsies in the diagnosis of adenomyosis. Fertil Steril 1995, 63:1347-1349.
23. Bazot M., Cortez A., Darai E., et al. Ultrasound compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 2001, 16:2427-2433.
24. Felde L., Bianchi S., Dorta M., et al. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil Steril 1992, 58:94-97.
25. Reinhold C., Atrim M., Mehio A., Zakarian R., Aldis A.E., Bret P.M. Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography. Radiology 1995, 197:609-614.
26. Brosens J, De Souza N, Barker F, et al. Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics. 1995;102:471-474.
27. Fusi L., Cloke B., Brosens J. The uterine junctional zone. Best Pract Res Clin Obstet Gynaecol 2006, 20:479-491.
28. Gordts S., Brosen J., Fusi L., et al. Uterine adenomyosis: a need for uniform terminology and consensus classification. Reprod Biomed Online 2008, 17:244-248.
29. Dueholm M., Lundorf E. Transvaginal ultrasound or MRI for diagnosis of adenomyosis. Curr Opin Obstet Gynecol 2007, 19:505-512.
30. Moghadam R., Lathi R., Shamohamady B., et al. Predictive value in magnetic resonance imaging in differentiating between leiomyoma and adenomyosis. JSLS 2006, 10:216-219.
31. Parazzini F., Vercellini P., Pazza S., et al. Risk factors for adenomyosis. Hum Reprod 1997, 12:1275-1279.
32. Vercellini P., Parazzini F., Oldani S., et al. Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod 1995, 10:1160-1162.
33. Levgur M., Abdai M.A., Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 2000, 95:688-691.
34. Taran F., Weaver A., Coddington C., et al. Characteristics indicating adenomyosis coexisting with leiomyomas: a case control study. Hum Reprod 2010, 25:1177-1182.
35. Harris W., Daniel J. Prior cesarean section: a risk factor for adenomyosis?. J Reprod Med 1985, 30:173-175.
36. Cohen I., Beyth Y., Repper R. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?. Gynecol Oncol 1995, 58:86-91.
37. Brosens J., Souza N., Barker Uterine junctional zone: function and disease. Lancet 1995, 346:558-560.
38. Salamanca A., Beltran E. Subendometrial contractility in menstrual phase visualized by transvaginal sonography in patients with endometriosis. Fertil Steril 1995, 64:193-195.
39. Nishida M. Relationship between the onset of dysmenorrhea and histologic findings in adenomyosis. Am J Obstet Gynecol 1991, 165:229-231.
40. Sedar B. Mechanisms of disease: endometriosis. N Engl J Med 2010, 360:268-279.
41. Devlieger R., D'Hooghe T., Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update 2003, 9:139-147.
42. Souza N., Brosens J., Schwieso J., et al. The potential value of magnetic resonance imaging in infertility. Clin Radiol 1995, 50:75-79.
43. Benagiano G., Bronsens, Carrara S. Adenomyosis: new knowledge is generating new treatment strategies. Women's Health 2009, 5:297-311.
44. Camargo F, Gayttan J, Caligara. Impact of ultrasound diagnosis of adenomyosis on the recipients of sibling oocytes. Fertil Steril. 76(suppl 1):S150.
45. Hirata J., Moghissi, Ginsburg K. Pregnancy after medical therapy of adenomyosis with gonadotropin-releasing hormone agonist. Fertil Steril 1993, 59:444-445.
46. Huang F., Kung F., Chang S., et al. Effects of short-course buserelin therapy on adenomyosis: a report of two cases. J Reprod Med 1999, 44:741-744.
47. Nelson J., Corson S. Long term management of adenomyosis with a gonadotropin releasing hormone agonist: a case report. Fertil Steril 1993, 59:441-443.
48. Silva P., Perkins H., Schauberger C. Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril 1994, 61:171-172.
49. Ozaki T., Takahashi K., Okada M., et al. Live birth after conservative surgery for severe adenomyosis following magnetic resonance imaging and gonadotropin-releasing hormone agonist therapy. Int J Fertil Women's Med 1999, 44:260-264.
50. Farquhar C. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynecol 2006, 20:603-626.
51. Fong Y., Singh K. Medical treatment of grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception 1999, 60:173-175.
52. Sheng J., Zhang Q., Zhang J. The LNG-IUS study on adenomyosis: a 3 year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 2009, 79:189-193.
53. Bragheto A., Caserta N., Bahamondes L., et al. Effectiveness of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by MRI. Contraception 2007, 76:195-199.
54. Fedele L., Bianchi S., Raffaelli R., et al. Treatment of adenomyosis-associated menorrhagia with levonorgestrel-releasing intrauterine device. Fertil Steril 1997, 68:436-439.
55. Ishihara H., Kitawaki J., Kado N. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril 2003, 79(suppl 1):735-742.
56. Igarashi M. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril 2000, 74:412-413.
57. Takebayashi T., Funjino, Umeski N., et al. Danazol suspension injected into the uterine cervix of patients with adenomyosis and myoma. Gynecol Obstet Invest 1995, 39:207-211.
58. Grow D., Filer R. Treatment of adenomyosis with long-term GnRh analogues: a case report. Obstet Gynecol 1991, 78:538-539.
59. Bulun S., Fang Z., Imir G., et al. Aromatase and endometriosis. Semin Reprod Med 2004, 22:45-50.
60. Noble L., Simpson E., Johns A., et al. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996, 81:174-179.
61. Nawathe A., Patwardhan S., Yates D., et al. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 2008, 115:818-822.
62. Furuhashi M., Miyabe Y., Katsumata Y., et al. Comparison of complications of vaginal hysterectomy in patients with leiomyomas and in patients with adenomyosis. Arch Gynecol Obstet 1998, 262:69-73.
63. Garry R., Gountain J., Mason S., et al. The eVALuate study: two parallel randomized trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ 2004, 8:494-591.
64. Candiani M., Izzo S., Bulfoni A., et al. Laparoscopic vs vaginal hysterectomy for benign pathology. Am J Obstet Gynecol 2009, 200:368.e1-368.e7.
65. Ghezzi F., Uccella S., Cromi A., et al. Postoperative pain after laparoscopic and vaginal hysterectomy for benign gynecologic disease: a randomized trial. Am J Obstet Gynecol 2010, 203:118.e1-118.e8.
66. McCausland A.M., McCausland V.M. Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am J Obstet Gynecol 1996, 174:1786-1794.
67. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update 1998, 4:323-336.
68. El Nashar S., Hopkins M., Creedon D. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol 2009, 113:97-106.
69. Kim M., Kim S., Kim N. Longer term results of uterine artery embolization for symptomatic adenomyosis. Interv. Radiol 2007, 188:176-181.
70. Goodwin S., McLuca B., Lee M., et al. Uterine artery embolization for the treatment of symptomatic uterine leiomyomata midterm results. J Vasc Interv Radiol 1999, 10:1159-1165.
71. Smith S., Sewall L., Handelsman A. A clinical failure of uterine fibroid embolization for treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol 1999, 10:1171-1174.
72. Wang P., Wei-Min L., Jong L.F., et al. Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma. Fertil Steril 2009, 92:876-885.
73. Felde L., Bianchi S., Zanotti M., et al. Fertility after conservative surgery for adenomyomas. Hum Reprod 1993, 8:1708-1710.
74. Wood C., Maher P., Hill D. Biopsy and conservative surgical treatment of adenomyosis. J Am Assoc Gynecol Laparosc 1994, 1:313-316.
75. Phillips D., Nathanson H., Milim S., et al. Laparoscopic bipolar coagulation for the conservative treatment of adenomyomata. J Am Assoc Gynecol Laparosc 1996, 4:19-24.
76. Levgur M. Therapeutic options for adenomyosis: a review. Arch Gynecol Obstet 2007, 276:1-15.
77. Fujishita A., Masuzaki H., Khan K., et al. Modified reduction surgery for adenomyosis: a preliminary report of the transverse H incision technique. Gynecol Obstet Invest 2004, 57:132-138.
78. Nishida M., Takano K., Arai Y. Conservative surgical management for diffuse uterine adenomyosis. Fertil Steril 2010, 94:715-719.
79. Yang Z., Cao Y., Hu L., et al. Feasibility of laparoscopic high intensity focused ultrasound treatment for patients with uterine localized adenomyosis. Fertil Steril 2009, 91:2338-2343.
80. Rabinovici J. New interventional techniques for adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006, 20:617-636.
81. Hindley J., Gedroyc W., Regan L., et al. MRI guidance of focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003, 226:897-905.
82. Stewart E., Rabinovici J., Tempany C., et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006, 85:22-29.
83. Leon-Villapalos J, Kaniorou-Larai M, Dziewulski P, et al. Full thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns. 205;31:1054-1044.
84. Shen S., Fennessy F., McDannold, et al. Image-guided thermal therapy of uterine fibroids. Semin Ultrasound CT MR 2009, 30:91-104.
85. Rabinovici J., Inbar Y., Eylon S. Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod 2006, 21:1255-1259.